AI-powered radiomics: revolutionizing detection of urologic malignancies

David G Gelikman1, Soroush Rais-Bahrami2,3,4, Peter A Pinto5

  • 1Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

PubMed
Summary

Artificial intelligence (AI)-powered radiomics enhances urologic oncology by improving cancer detection and prognosis for prostate, kidney, and bladder cancers. Further multicenter studies are needed to validate these AI advancements.